Assistant Professor, Internal Medicine, University of Michigan Medical School
Oncology
Dr. Attaphol Pawarode, MD
|
|
Give Review
Attaphol Pawarode works in the field of Oncology. He received 1 awards: "CMS Meaningful Use Stage 1 Certification". Attaphol Pawarode has written publications. He has 22 publications published with PubMed. The lastest paper is: 'Natural history of untreated primary hepatocellular carcinoma: a retrospective study of 157 patients.' He accepts all Medicare patients.
Publications
- Combination Therapy for GVHD Prophylaxis with Etanercept and Extracorporeal Photopheresis: Results of a Phase II Clinical Trial.
- Analytic morphomics: a novel CT imaging approach to quantify adipose tissue and muscle composition in allogeneic hematopoietic Cell transplantation.
- Reducing Treatment-related Mortality Did Not Improve Outcomes of Allogeneic Myeloablative Hematopoietic Cell Transplantation for High-Risk Multiple Myeloma: A Universi...
- Quantitative Analysis of MR Imaging to Assess Treatment Response for Patients with Multiple Myeloma by Using Dynamic Intensity Entropy Transformation: A Preliminary St...
- FLT3 mutational status is an independent risk factor for adverse outcomes after allogeneic transplantation in AML.
- Allogeneic transplantation with myeloablative FluBu4 conditioning improves survival compared to reduced intensity FluBu2 conditioning for Acute myeloid leukemia in rem...
- Predictive Value of Bronchiolitis Obliterans Syndrome Stage 0p in Chronic Graft-versus-Host Disease of the Lung.
- Etanercept plus Topical Corticosteroids as Initial Therapy for Grade One Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation.
- Vorinostat plus tacrolimus and mycophenolate to prevent graft-versus-host disease after related-donor reduced-intensity conditioning allogeneic haemopoietic stem-Cell ...
- TNF-inhibition with etanercept for Graft versus host disease prevention in high risk HCT: Lower TNFR1 levels correlate with better outcomes.
- Clofarabine and busulfan conditioning facilitates enGraftment and provides significant antitumor activity in nonremission hematologic malignancies.
- Long-term safety and efficacy of cyclosporin A therapy for T-cell large granular lymphocyte Leukemia.
- T/B and not T/B: high frequency of B-cell dyscrasias in T-LGL Leukemia.
- Acute myeloid leukemia developing during imatinib mesylate therapy for chronic myeloid leukemia in the absence of new cytogenetic abnormalities.
- Differential effects of the immunosuppressive agents cyclosporin A, tacrolimus and sirolimus on drug transport by multidrug resistance proteins.
- Isochromosome 1q in a myelodysplastic syndrome after treatment for Acute promyelocytic leukemia.
- Simultaneous presentation of Acute monoblastic leukemia and mantle cell lymphoma: case report and review of the literature.
- Independent risk factors and natural history of renal dysfunction in liver transplant recipients.
- Outcomes of primary hepatoCellular carcinoma treatment: an 8-year experience with 368 patients in Thailand.
- Natural history of untreated primary hepatoCellular carcinoma: a retrospective study of 157 patients.
- Ruptured primary hepatoCellular carcinoma at Chulalongkorn University Hospital: a retrospective study of 32 cases.
Procedures Preformed
- Bone Marrow Transplant
- HPC Transplantation (Stem Cell Transplant)
Conditions Treated
- Acute Leukemia
- Anemia
- Antiphospholipid Syndrome (APS)
- Basal Cell Carcinoma
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
University at Buffalo -
Chulalongkorn University Faculty of Medicine
Hospital
-
University of Michigan Hospitals and Health Centers
Drug Facts
| NPI NUMBER | 1326255951 | |
| NPPES Provider LastName | PAWARODE | |
| NPPES Provider FirstName | ATTAPHOL | |
| NPPES Provider ZIPCode | 481099814 | |
| NPPES Provider State | MI | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 833.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 20.0 | |
| Percent Opioid Claims | 2.4 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1326255951 |
| Last Name Of The Provider | PAWARODE |
| First Name Of The Provider | ATTAPHOL |
| View All |
Similar Doctors
|
|
Dr. Paula L. Bockenstedt, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Francis P. Worden, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Gregory P. Kalemkerian, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Nathalie A. Brophy, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kathleen A. Cooney, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Kojo S. Elenitoba-Johnson, MD |
|
|
Dr. Norah L. Henry, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Maha H. Hussain, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Rupali Roy, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Cheryl A. Utiger, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christine M. Veenstra, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kemp B. Cease, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Scott M. Schuetze, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Lan G. Coffman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ronald J. Buckanovich, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sofia D. Merajver, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Anne F. Schott, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Raymond M. Esper, MD
This Doctor is OpenDoctor Recommended.
|